Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP)
Universite de Picardie Jules Verne
34 participants
Jan 1, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants receive application of a neutral cream (MEDICAFARM) with verbal and behavioral suggestions that it may cause localized pain. Researchers wear gloves during application and emphasize potential discomfort, stating effects may intensify with movement.
Participants receive identical application of the neutral cream but are informed it is inert and harmless. Researchers apply the cream without gloves and provide neutral instructions.
Participants undergo assessment procedures including: * Pre- and post-application gait analysis (GAITRite mat, Zebris treadmill) * Physiological monitoring (EMG, HRV, EDA) * Identical questionnaires (BPI, TSK, FACS, PCS, VAS)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06929559